CLOUGH CAPITAL PARTNERS L P

Position in KRYS — Krystal Biotech, Inc.

CIK 1276144 Boston, MA

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,440,549

+$1,244,313 QoQ

Shares Held

9,257

+8.9% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#132

of 419 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLOUGH CAPITAL PARTNERS L P holds $12,298,984 across 3 Biotechnology names. KRYS ranks #3 (28.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	98,337	$5,363,299
2	IBRX	ImmunityBio, Inc.	399,216	$3,495,136
3	KRYS	Krystal Biotech, Inc. This page	9,257	$3,440,549

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,440,549	9,257	+8.9%	Shares	Defined	2026-08-14
2026-03-31	$2,196,236	8,502	+8.9%	Shares	Defined	2026-05-15
2025-12-31	$1,924,491	7,806	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.